We reported that a novel regulatory pathway composed of LINC01296/miR-141-3p/ZEB1-ZEB2 is involved in the metastasis progression of NSCLC and CRC and provides potential biomarkers and therapeutic targets for the diagnosis and treatment of tumor metastasis. This evidence concerns the gene ZEB1 and colorectal carcinoma.